ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

In Brief: White House Finally Okays Marks To Panel; NCAB Seeks More Data In RFP Announcements

July 2, 1976

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

ASCO Awards Contract For D.C. Office

January 5, 1990

In Brief CCOP Prospects Submit 130 Letters Of Intent; DeVita recovering On Schedule from Surgery

September 26, 1986

AACR Plans Office in Singapore.

November 30, 2007